Genetics of Alzheimer's Disease: An Insight Into Presenilins and Apolipoprotein E Instigated Neurodegeneration

REFERENCES

• Abdul, H. M., Sultana, R., St Clair, D. K., Markesbery, W. R., & Butterfield, D. A. (2008). Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age. Free Radical Biology and Medicine, 45(10), 1420–1425.
   Google Scholar
• Albrecht, S., Bogdanovic, N., Ghetti, B., Winblad, B., & LeBlanc, A. C. (2009). Caspase-6 activation in familial Alzheimer disease brains carrying amyloid precursor protein or presenilin I or presenilin II mutations. Journal of Neuropatholology and Experimental Neurology, 68(12), 1282–1293.
   Google Scholar
• Bales, K. R. (2010). Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Neuropharmacology, 59(4–5), 295–302.
   Google Scholar
• Bales, K. R., Liu, F., Koger, D., Wu, S., Mabry, T., Christie, M., (2008). Apolipoprotein E-isoform dependent decrease in brain β-amyloid following treatment of PDAPP transgenic mice with a LXR agonist.Society of Neuroscience Abstracts, 45, 14.
   Google Scholar
• Bales, K. R., Liu, F., Wu, S., Lin, S., Koger, K., DeLong, C., (2009). Human APOE isoform-dependent effects on brain beta amyloid levels in PDAPP transgenic mice. The Journal of Neuroscience, 29(21), 6771–6779.
   Google Scholar
• Bales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., et al. (1999). Apolipoprotein E is essential for amyloid deposition in the APP (V717F) transgenic mouse model of Alzheimer's disease.Proceedings of the National Academy of Sciences, USA, 96(26), 15233–15238.
   Google Scholar
• Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altsteil, L., Bender, M., (1997). Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nature Genetics, 17(3), 263–264.
   PubMed Web of Science ®Google Scholar
• Bergmans, B. A., & De Strooper, B. (2010). Gamma-secretases: From cell biology to therapeutic strategies. The Lancet Neurology, 9(2), 215–226.
   Google Scholar
• Bettens, K., Sleegers, K., & Van Broeckhoven, C. (2010). Current status on Alzheimer disease molecular genetics: From past, to present, to future. Human Molecular Genetics, 19(R1), R4–R11.
   PubMedGoogle Scholar
• Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1995). Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmylinating glia of the peripheral nervous system. The Journal of Clinical Investigation, 76(4), 1501–1513.
   Google Scholar
• Bruno, E., Quattrocchi, G., Nicoletti, A., Le Pira, F., Maci, T., Mostile, G., (2010). Lack of interaction between LRP1 and A2M polymorphisms for the risk of Alzheimer disease. Neuroscience Letters, 482(2), 112–116.
   Google Scholar
• Cervantes, S., Saura, C. A., Pomares, E., Gonzalez-Duarte, R., & Marfany, G. (2004). Functional implications of the presenilin dimerization: Reconstitution of γ-secretase activity by assembly of a catalytic site at the dimer interface of two catalytically inactive presenilins. Journal of Biological Chemistry, 279(35), 36519–36529.
   Google Scholar
• Corder, E. H., Saunders, A. M., Risch, N. J., Strittmater, W. J., Schmechel, D. E., Gaskell, P. C., Jr., (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7(2), 180–184.
   PubMed Web of Science ®Google Scholar
• De Gasperi, R., Sosa, M. A., Dracheva, S., & Elder, G.. (2010). A Presenilin-1 regulates induction of hypoxia inducible factor-1α: Altered activation by a mutation associated with familial Alzheimer's disease. Molecular Neurodegeneration, 5, 38.
   Google Scholar
• De Strooper, B. (2003). Aph-1, pen-2, and nicastrin with presenilin generate an active γ-secretase complex. Neuron, 38(1), 9–12.
   PubMed Web of Science ®Google Scholar
• Elder, G. A., Gama Sosa, M. A., De Gasperi, R., Dickstein, D. L., & Hof, P. R. (2010). Presenilin transgenic mice as models of Alzheimer's disease. Brain Structure and Function, 214(2–3), 127–143.
   Google Scholar
• Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S. Y., Dence, C. S., Shah, A. R., (2005). Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans. Annals of Neurology, 59(3), 512–519.
   Google Scholar
• Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., (1997). Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. The Journal of the American Medical Association, 278(16), 1349–1356.
   PubMed Web of Science ®Google Scholar
• Galimberti, D., & Scarpini, E. (2010). Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration. International Journal of Clinical and Experimental Medicine, 3(2), 129–143.
   PubMed Web of Science ®Google Scholar
• Gama Sosa, M. A., Gasperi, R. D., Rocher, A. B., Wang, A. C., Janssen, W. G., Flores, T., (2010). Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations. American Journal of Pathology, 176(1), 353–368.
   Google Scholar
• Ghidoni, R., Benussi, L., Paterlini, A., Missale, C., Usardi, A., Rossi, R., (2007). Presenilin 2 mutations alter cystatin C trafficking in mouse primary neurons. Neurobiology of Aging, 28(3), 371–376.
   Google Scholar
• Ghidoni, R., Paterlini, A., Albertini, V., Glionna, M., Monti, E., Schiaffonati, L., (2009). Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer's disease. Neurobiology of Aging, in press.
   Google Scholar
• Green, K. N., Demuro, A., Akbari, Y., Hitt, B. D., Smith, I. F., Parker, I., (2008). SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. Journal of Cell Biology, 181(7), 1107–1116.
   PubMed Web of Science ®Google Scholar
• Grimmer, T., Tholen, S., Yousefi, B. H., Alexopoulos, P., Forschler, A., Forstl, H., (2010). Progression of cerebral amyloid load is associated with the apolipoprotein E epsilon4 genotype in Alzheimer's disease. Biological Psychiatry, 68(10), 879–884.
   PubMed Web of Science ®Google Scholar
• Guyant-Marechal, L., Campion, D., & Hannequin, D. (2009). Alzheimer disease: Autosomal dominant forms. Revue Neurologique, (Paris), 165(3), 223–231.
   Google Scholar
• Hardy, J. (1992). Framing β-amyloid. Nature Genetics, 1(4), 233–234.
   Google Scholar
• Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics, 41(10), 1088–1093.
   PubMed Web of Science ®Google Scholar
• Hashimoto, Y., Ito, Y., Arakawa, E., Kita, Y., Terashita, K., Niikura, T., (2002). Neurotoxic mechanisms triggered by Alzheimer's disease-linked mutant M146L presenilin 1: Involvement of NO synthase via a novel pertussis toxin target. Journal of Neurochemistry, 80(3), 426–437.
   Google Scholar
• Hashimoto, Y., Niikura, T., Ito, Y., & Nishimoto, I. (2000). Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein. The Journal of Biological Chemistry, 275(44), 34541–34551.
   Google Scholar
• Hashimoto, Y., Niikura, T., Ito, Y., Sudo, H., Hata, M., Arakawa, E., (2001). Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults. Journal of Neuroscience, 21(23), 9235–9245.
   PubMed Web of Science ®Google Scholar
• Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Satorius, L. J., et al. (2000). Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences, USA, 97(6), 2892–2897.
   Google Scholar
• Hyman, B. T., West, H. L., Rebeck, G. W., Buldyrev, S. V., Mantegna, R. N., Ukleia, M., et al. (1995). Quantitative analysis of senile plaques in Alzheimer disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proceedings of the National Academy of Sciences, USA, 92(8), 3586–3590.
   Google Scholar
• Ikeuchi, T., Kaneko, H., Miyashita, A., Nozaki, H., Kasuga, K., Tsukie, T., (2008). Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations. Dementia and Geriatric and Cognitive Disorders, 26(1), 43–49.
   Google Scholar
• Irizarry, M. C., Rebeck, G. W., Cheung, B., Bales, K. R., Paul, S. M., Holtzman, D. M., (2000). Modulation of Aβ deposition in APP transgenic mice by an apolipoprotein E null background. Annals of the New York Academy of Sciences, 920, 171–178.
   PubMedGoogle Scholar
• Ito, Y., Ishii, A., Passmore, A. P., & McIlroy, S. P. (2007). Analysis of alteration of p75NTR processing and signalling by PS2 mutation and gamma-secretase inhibition. Neurobiology of Disease, 27(3), 258–264.
   Google Scholar
• Iurescia, S., Fioretti, D., Mangialasche, F., & Rinaldi, M. (2010). The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: Emerging gene-based therapeutic approaches. Journal of Alzheimers Disease, 21(1), 35–48.
   Google Scholar
• Kecmanovic, M., Dobricic, V., Dimitrijevic, R., Keckarevic, D., Savic-Pavicevic, D., Keckarevic-Markovic, M., (2010). Schizophrenia and apolipoprotein E gene polymorphism in Serbian population. International Journal of Neuroscience, 120(7), 502–506.
   PubMed Web of Science ®Google Scholar
• Kim, K. S., Wegiel, J., Sapienza, V., Chen, J., Hong, H., & Wisniewski, H. M. (1997). Immunoreactivity of presenilin- 1 in human, rat and mouse brain. Brain Research, 757(1), 159–163.
   Google Scholar
• Koo, E. H., & Kopan, R. (2004). Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. Nature Medicine, (10 Suppl), S26–S33.
   Google Scholar
• Kumar, V. B., Franko, M., Banks, W. A., Kasinadhuni, P., Farr, S. A., Vyas, K., (2009). Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing. Journal of Experimental Biology, 212(4), 494–498.
   Google Scholar
• Lah, J. J., Heilman, C. J., Nash, N. R., Rees, H. D., Yi, H., Counts, S. E., (1997). Light and electron microscopic localization of presenilin1 in primate brain. The Journal of Neuroscience, 17(6), 1971–1980.
   Google Scholar
• Lambert, J. C., & Amouyel, P. (2007). Genetic heterogeneity of Alzheimer's disease: Complexity and advances.Psychoneuroendocrinology, 32(Suppl 1), S62–S70.
   PubMed Web of Science ®Google Scholar
• Lambert, J. C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics, 41(10), 1094–1099.
   PubMed Web of Science ®Google Scholar
• Langbaum, J. B., Chen, K., Caselli, R. J., Lee, W., Reschke, C., Bandy, D., (2010). Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele. Archives of Neurology, 67(4), 462–468.
   Google Scholar
• Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, H., (1995). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science, 269(5226), 973–977.
   PubMed Web of Science ®Google Scholar
• Liang, G., Wang, Q., Li, Y., Kang, B., Eckenhoff, M. F., Eckenhoff, R. G., (2008). A presenilin-1 mutation renders neurons vulnerable to isoflurane toxicity. Anesthesia and Analgesia, 106(2), 492–500.
   Google Scholar
• Liang, P., Pan, Y. X., Zhao, X. M., Du, H. Z., & Zhang, J. M. (2005). Study on expression of PS1 in APP-PS1 double gene stably transfected cell lines and its relation to gamma-secretase. Zhonghua Bing Li Xue Za Zhi, 34(5), 297–301.
   Google Scholar
• Mauch, D. H., Nagler, K., Schumacher, S., Goritz, C., Muller, E. C., Otto, A., (2001). CNS synaptogenesis promoted by glia-derived cholesterol. Science, 294(5545), 1354–1357.
   PubMed Web of Science ®Google Scholar
• Mi, W., Jung, S. S., Yu, H., Schmidt, S. D., Nixon, R. A., Mathews, P. M., (2009). Complexes of amyloid-β and cystatin C in the human central nervous system. Journal of Alzheimers Disease, 18(2), 273–280.
   Google Scholar
• Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., (2009). APOE predicts Aβ but not Tau Alzheimer's pathology in cognitively normal aging. Annals of Neurology, 67(1), 122–131.
   Google Scholar
• Muller, T., Meyer, H. E., Egensperger, R., & Marcus, K. (2008). The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer's disease. Progress in Neurobiology, 85(4), 393–406.
   Google Scholar
• Munter, L. M., Botev, A., Richter, L., Hildebrand, P. W., Althoff, V., Weise, C., (2010). Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif. Journal of Biological Chemistry, 285(28), 21636–21643.
   Google Scholar
• Nahalkova, J., Volkmann, I., Aoki, M., Winblad, B., Bogdanovic, N., Tjernberg, L. O., (2010). CD147, a gamma-secretase associated protein is upregulated in Alzheimer's disease brain and its cellular trafficking is affected by presenilin-2. Neurochemistry International, 56(1), 67–76.
   Google Scholar
• Niikura, T., Yamada, M., Chiba, T., Aiso, S., Matsuoka, M., & Nishimoto, I. (2004). Characterization of V642I-AbetaPP-induced cytotoxicity in primary neurons. Journal of Neuroscience Research, 77(1), 54–62.
   Google Scholar
• Nikisch, G., Wiedemann, G., Kiessling, B., & Hertel, A. (2008). Familial Alzheimer's disease with presenilin 2 N141I mutation. A case report. Fortschritte der Neurologie-Psychiatrie, 76(10), 606–609.
   Google Scholar
• Nizzari, M., Venezia, V., Repetto, E., Caorsi, V., Magrassi, R., Gagliani, M. C., (2007). Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1, 2 signaling. The Journal of Biological Chemistry, 282(18), 13833–13844.
   Google Scholar
• Obulesu, M., & Rao, D. M. (2010a). DNA damage and impairment of DNA repair in Alzheimer's Disease. The International Journal of Neuroscience, 120(6), 397–403.
   PubMed Web of Science ®Google Scholar
• Obulesu, M., & Rao, D. M. (2010b). Animal models of Alzheimer's disease: An understanding of pathology and therapeutic avenues. The International Journal of Neuroscience, 120(8), 531–537.
   PubMed Web of Science ®Google Scholar
• Obulesu, M., Rao, D. M., & Shamasundar, N. M. (2009). Studies on genomic DNA stability in aluminium maltolate treated aged New Zealand rabbit: Relevance to the Alzheimer's animal model. Journal of Clinical and Medicinal Research, 1(4), 212–218.
   Google Scholar
• Odero, G. L., Oikawa, K., Glazner, K. A., Schapansky, J., Grossman, D., Thiessen, J. D., (2010). Evidence for the involvement of calbindin D28k in the presenilin 1 model of Alzheimer's disease. Neuroscience, 169(1), 532–543.
   Google Scholar
• Peers, C., Smith, I. F., Boyle, J. P., & Pearson, H. A. (2004). Remodelling of Ca2+ homeostasis in type I cortical astrocytes by hypoxia: Evidence for association with Alzheimer's disease. Biological Chemistry, 385(3–4), 285–289.
   Google Scholar
• Placanica, L., Tarassishin, L., Yang, G., Peethumnongsin, E., Kim, S. H., Zheng, H., (2009). Pen2 and presenilin-1 modulate the dynamic equilibrium of presenilin-1 and presenilin-2 gamma-secretase complexes. The Journal of Biological Chemistry, 284(5), 2967–2977.
   Google Scholar
• Prince, J. A., Zetterberg, H., Andreasen, N., Marcusson, J., & Blennow, K. (2004). APOE 34 allele is associated with reduced cerebrospinal fluid levels of Aβ 42. Neurology, 62(11), 2116–2118.
   PubMed Web of Science ®Google Scholar
• Riddell, D. R., Zhou, H., Comery, T. A., Kouranova, E., Lo, C. F., Warwick, H. K., (2007). The LXR agonist T0901317 selectively lowers hippocampal Ab42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Molecular and Cellular Neuroscience, 34(4), 621–628.
   PubMed Web of Science ®Google Scholar
• Rocchi, A., Pellegrini, S., Siciliano, G., & Murri, L. (2003). Causative and susceptibility genes for Alzheimer's disease: A review. Brain Research Bulletin, 61(1), 1–24.
   Web of Science ®Google Scholar
• Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., (1995). Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature, 376(6543), 775–778.
   PubMed Web of Science ®Google Scholar
• Saunders, A. M., Strittmatter, W. J., Schmechel, D., George-Hyslop, P. H., Pericak- Vance, M. A., Joo, S. H., (1993). Association of apolipoprotein allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43(8), 1467–1472.
   PubMed Web of Science ®Google Scholar
• Saura, C. A. (2010). Presenilin/γ-secretase and inflammation. Frontiers of Aging Neuroscience, 2, 16.
   Google Scholar
• Saura, C. A., Tomita, T., Davenport, F., Harris, C. L., Iwatsubo, T., & Thinakaran, G. (1999). Evidence that intramolecular associations between presenilin domains are obligatory for endoproteolytic processing. The Journal of Biological Chemistry, 274(20), 13818–13823.
   Google Scholar
• Schmechel, D. E., Saunders, A. M., Strittmater, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., et al. (1993). Increased amyloid beta peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proceedings of the National Academy of Sciences, USA, 90(20), 9649–9653.
   Google Scholar
• Schon, E. A., & Area-Gomez, E. (2010). Is Alzheimer's disease a disorder of mitochondria-associated membranes? Journal of Alzheimers Disease, 20(Suppl 2), S281–S292.
   Google Scholar
• Selkoe, D. J. (2002). Alzheimer's disease is a synaptic failure. Science, 298(5594), 789–791.
   PubMed Web of Science ®Google Scholar
• Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., (1995). Cloning of novel gene bearing missense mutations in early onset familial Alzheimer's disease. Nature, 375(6534), 754–760.
   PubMed Web of Science ®Google Scholar
• Strittmatter, W. J., & Roses, A. D. (1995). Apolipoprotein E and Alzheimer disease. Proceedings of the National Academy of Sciences, USA, 92(11), 4725–4727.
   Google Scholar
• Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., et al. (1993). Apolipoprotein E: High-avidity binding to β amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences, USA, 90(5), 1977–1981.
   Google Scholar
• Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y., (2003). The role of presenilin cofactors in the γ-secretase complex. Nature, 422(6930), 438–441.
   PubMed Web of Science ®Google Scholar
• Thinakaran, G., Borchelt, D. R., Lee, M. K., Slunt, H. H., Spitzer, L., Kim, G., (1996). Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron, 17(1), 181–190.
   PubMed Web of Science ®Google Scholar
• Tirado, V., Motta, M., Aguirre-Acevedo, D. C., Pineda, D. A., & Lopera, F. (2008). Analysis of intrusive errors in a memory test as possible pre-clinical marker of familial Alzheimer disease, in E280A presenilin-1 mutation carrier. Revista de Neurologia, 47(6), 290–294.
   Google Scholar
• Veeraraghavalu, K., Choi, S. H., & Sisodia, S. S. (2010). Expression of familial Alzheimer's disease-linked human presenilin 1 variants impair enrichment-induced adult hippocampal neurogenesis. Neurodegenerative Diseases, 7(1–3), 46–49.
   Google Scholar
• Wan, J., Fu, A. K., Ip, F. C., Ng, H. K., Hugon, J., Page, G., (2010). Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: Implications in Alzheimer's disease. The Journal of Neuroscience, 30(20), 6873–6881.
   Google Scholar
• Wanngren, J., Franberg, J., Svensson, A. I., Laudon, H., Olsson, F., Winblad, B., (2010). The large hydrophilic loop of presenilin 1 is important for regulating gamma-secretase complex assembly and dictating the amyloid beta peptide (Abeta) profile without affecting Notch processing. The Journal of Biological Chemistry, 285(12), 8527–8536.
   Google Scholar
• Weggen, S., Diehlmann, A., Buslei, R., Beyreuther, K., & Bayer, T. A. (1998). Prominent expression of presenilin-1 in senile plaques and reactive astrocytes in Alzheimer's disease brain. Neuroreport, 9(14), 3279–3283.
   Google Scholar
• Weisgraber, K. H. (1994). Apolipoprotein E: Structure function relationships. Advances in Protein Chemistry, 45, 249–302.
   PubMedGoogle Scholar
• Williamson, J., Goldman, J., & Marder, K. S. (2009). Genetic aspects of Alzheimer disease. Neurologist, 15(2), 80–86.
   Google Scholar
• Yagi, T., Giallourakis, C., Mohanty, S., Scheidig, C., Shen, J., Zheng, H., (2008). Defective signal transduction in B lymphocytes lacking presenilin proteins. Proceedings of the National Academy of Sciences, USA, 105(3), 979–984.
   Google Scholar
• Yin, Y. I., Bassit, B., Zhu, L., Yang, X., Wang, C., & Li, Y. M. (2007). {gamma}-secretase substrate concentration modulates the Abeta42/Abeta40 ratio: Implications for Alzheimer's disease. The Journal of Biological Chemistry, 282(32), 23639–23644.
   PubMed Web of Science ®Google Scholar
• Zhu, M., Gu, F., Shi, J., Hu, J., Hu, Y., & Zhao, Z. (2008). Increased oxidative stress and astrogliosis responses in conditional double-knockout mice of Alzheimer-like presenilin-1 and presenilin-2. Free Radical Biology and Medicine, 45(10), 1493–1499.
   Google Scholar
• Zou, K., Hosono, T., Nakamura, T., Shiraishi, H., Maeda, T., Komano, H., (2008). Novel role of presenilins in maturation and transport of integrin beta 1. Biochemistry, 47(11), 3370–3378.
   Google Scholar